miR-182-5p, miR-23a-3p |
Lipopolysaccharide (LPS)-induced ARDS |
Mesenchymal stem cells (MSCs) |
Ikbkb, USP5 |
Immunomodulation and tissue recovery via IKKβ/nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB)/hedgehog suppression |
[35] |
miR-377-3p |
LPS-induced ARDS |
Umbilical cord-derived MSCs (UCMSCs) |
Regulatory associated protein of mammalian target of mTOR (RPTOR) |
Injury recovery by RPTOR suppression and inducing autophagy |
[36] |
miR-22-3p |
LPS-induced ARDS |
Umbilical cord blood-derived MSCs (UCBMSCs) |
Frizzled class receptor 6 (FZD6)/Wnt |
Immunomodulation via decreasing FZD6 expression, leading to NF-κB suppression |
[37] |
miR-150 |
LPS-induced ARDS |
Bone marrow-derived MSCs (BMSCs) |
MAPK |
Immunomodulation via suppression of MAPK-associated proteins and cleaved caspase-3 and B-cell lymphoma 2 (Bcl-2) promotion |
[38] |
miR-30b-3p |
LPS-induced ARDS |
MSCs |
SAA3 |
Immunomodulation via suppression of serum amyloid A-3 (SAA3) |
[39] |
miR-425 |
HYRX-induced ARDS |
BMSCs |
PTEN |
PI3K/AKT upregulation via suppressing PTEN |
[40] |
miR-126 |
Histone-induced ARDS |
Adipose-derived MSCs (AMSCs) |
PI3K/AKT |
PI3K/AKT upregulation |
[41] |
Unknown |
IIR-induced ARDS |
BMSCs |
TLR4/NF-κB |
Immunomodulation via downregulation of toll-like receptor 4 (TLR4)/NF-κB pathway |
[42] |
miR-384-5p |
LPS-induced ARDS |
BMSCs |
Beclin-1 |
Immunomodulation via inducing autophagy in disordered macrophages |
[43] |
miR-451 |
Burn-induced ARDS |
UCMSCs |
TLR4/NF-κB |
Immunomodulation via TLR4 and NF-κB downregulation |
[31] |